TAK

Takeda PharmaceuticalC

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$19.50

Analysis reference price unavailable

Analysis 2026-01-30 · RankAlpha Sentiment AI

Most likely

Base case

60%

Probability

Target price

$17.00

Analysis reference price unavailable

Analysis 2026-01-30 · RankAlpha Sentiment AI

B-

Bear case

20%

Probability

Target price

$14.87

Analysis reference price unavailable

Analysis 2026-01-30 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-01-30

AI commentary

Consensus targets cluster around the current price with a median near the mid-$16s and a high near $19.5, implying limited near-term upside from the anchor absent positive clinical or regulatory news. Market tone is neutral-to-cautious; upside is contingent on successful readouts, credible guidance, and execution on cost synergies.

RankAlpha Sentiment AI - 2026-01-30

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-04-30eventNext quarterly results (assumed window)Medium impact

Next quarterly earnings release; no firm date published in reviewed sources so a conservative estimate is used (assumed end of window) — market reactions likely to reprice guidance and analyst targets [#SERP-1].

2026-04-30catalystAnalyst target revisionsHigh impact

Analyst target updates following earnings or guidance changes; current scraped targets show a tight median/high range that could be nudged by results or guidance shifts [#SERP-1], [#SERP-3].

2027-01-30catalystPipeline readouts and strategic executionHigh impact

Longer-term clinical readouts and portfolio/efficiency execution could materially alter valuation over the next year; timeline conservatively set one year out when specific dates are not publicly disclosed.

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-01-30 • Updated nightlySource: Internal modelMethodology